1. Home
  2. VIRC vs ONCY Comparison

VIRC vs ONCY Comparison

Compare VIRC & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virco Manufacturing Corporation

VIRC

Virco Manufacturing Corporation

HOLD

Current Price

$6.09

Market Cap

89.5M

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$1.01

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIRC
ONCY
Founded
1950
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Specialties
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.5M
94.0M
IPO Year
1995
2002

Fundamental Metrics

Financial Performance
Metric
VIRC
ONCY
Price
$6.09
$1.01
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$7.30
$7.33
AVG Volume (30 Days)
38.5K
966.8K
Earning Date
04-08-2026
05-13-2026
Dividend Yield
1.66%
N/A
EPS Growth
N/A
N/A
EPS
0.16
N/A
Revenue
$199,652,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.77
$2,505.00
P/E Ratio
$37.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.16
$0.33
52 Week High
$9.63
$1.51

Technical Indicators

Market Signals
Indicator
VIRC
ONCY
Relative Strength Index (RSI) 50.13 49.21
Support Level $6.02 $0.94
Resistance Level $6.53 $1.13
Average True Range (ATR) 0.27 0.09
MACD 0.02 0.01
Stochastic Oscillator 71.96 46.97

Price Performance

Historical Comparison
VIRC
ONCY

About VIRC Virco Manufacturing Corporation

Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: